217
Participants
Start Date
December 9, 2014
Primary Completion Date
June 26, 2018
Study Completion Date
June 28, 2018
bimagrumab
Bimagrumab will be administered as an intravenous infusion starting on Day 1 until week 21.
placebo
Placebo will be administered as an intravenous infusion starting on Day 1 until week 21.
Novartis Investigative Site, Brussels
Novartis Investigative Site, Geneva
Novartis Investigative Site, Copenhagen
Novartis Investigative Site, Copenhagen NV
Novartis Investigative Site, Leuven
Novartis Investigative Site, St Albans
Novartis Investigative Site, Basel
Novartis Investigative Site, Adelaide
Novartis Investigative Site, Berlin
Novartis Investigative Site, Taipei
Novartis Investigative Site, Prague
Novartis Investigative Site, Bundang Gu
Novartis Investigative Site, Suwon
Novartis Investigative Site, High Point
Novartis Investigative Site, Madrid
Novartis Investigative Site, Getafe
Novartis Investigative Site, Spartanburg
Novartis Investigative Site, Gainesville
Novartis Investigative Site, Toulouse
Novartis Investigative Site, Gainesville
Novartis Investigative Site, Orlando
Novartis Investigative Site, Miami Lakes
Novartis Investigative Site, Miami
Novartis Investigative Site, Pessac
Novartis Investigative Site, Montpellier
Novartis Investigative Site, Columbus
Novartis Investigative Site, Madison
Novartis Investigative Site, Rochester
Novartis Investigative Site, Brno
Novartis Investigative Site, Little Rock
Novartis Investigative Site, Opava
Novartis Investigative Site, Paris
Novartis Investigative Site, Mesquite
Novartis Investigative Site, San Antonio
Novartis Investigative Site, Cypress
Novartis Investigative Site, Würzburg
Novartis Investigative Site, Moscow
Novartis Investigative Site, Moscow
Novartis Investigative Site, Yaroslavl
Novartis Investigative Site, Saint Petersburg
Novartis Investigative Site, La Jolla
Novartis Investigative Site, Farmington
Novartis Investigative Site, Boston
Novartis Investigative Site, Ōbu
Novartis Investigative Site, Toyohashi
Novartis Investigative Site, Mizunami
Novartis Investigative Site, Nara
Novartis Investigative Site, Kawachi-Nagano
Novartis Investigative Site, Kitaadachigun Inamachi
Novartis Investigative Site, Kitamoto
Novartis Investigative Site, Yoshinogawa
Novartis Investigative Site, Itabashi Ku
Novartis Investigative Site, Kiyose
Novartis Investigative Site, Koto-ku
Novartis Investigative Site, Musashimurayama
Novartis Investigative Site, Seoul
Novartis Investigative Site, Albacete
Novartis Investigative Site, Barcelona
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY